Psoriatic arthritis impacts skin and joints. It causes pain, swelling, and stiffness. This condition often follows psoriasis.

Upadacitinib and secukinumab for PsA offers comparable improvements in skin and joint symptoms, but adalimumab offers superior pain relief.

Hand swelling, or oedema, can stem from various causes including heat, high salt intake, exercise, and pregnancy. Underlying conditions like lymphedem ...

Treatment with guselkumab led to improvements in disease activity over 1 year among patients with PsA and showed a high retention rate.

Pregnancies with psoriatic arthritis are associated with increased odds of preterm births, with disease load before pregnancy ...

Arthritis in India is a growing health crisis, with nearly one in six Indians suffering from musculoskeletal and ...

Modern lifestyles are fueling a surge in fatty liver disease, a condition where excess fat accumulates in the liver. Early ...

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded indications for YUFLYMA® (adalimumab-aaty) and its unbranded version, to include the treatment of ...

Still given JNJ has most of the rights to market and sell icontrokinra, is there any pressing need to complete a full, ...

What is World Arthritis Day 2025? It’s a global push on Oct 12 to spotlight joint diseases, drive action, and empower millions living with arthritis.